神经退行性疾病的生物标志物导向分类方案。 - Suppr

Biomarker-guided classification scheme of neurodegenerative diseases.

作者信息

Baldacci Filippo, Lista Simone, Garaci Francesco, Bonuccelli Ubaldo, Toschi Nicola, Hampel Harald

机构信息

Department of Clinical and Experimental Medicine, University of Pisa, Pisa 56126, Italy.

Institute of Memory and Alzheimer's Disease (IM2A), Brain and Spine Institute (ICM) UMR S 1127, Department of Neurology, Pitié-Salpêtrière Hospital, Paris 75651, France.

出版信息

J Sport Health Sci. 2016 Dec;5(4):383-387. doi: 10.1016/j.jshs.2016.08.007. Epub 2016 Aug 23.

DOI:10.1016/j.jshs.2016.08.007

PMID:30356557

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6188916/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3666/6188916/e71382b0ee87/jshs321-fig-0001.jpg

相似文献

Biomarker-guided classification scheme of neurodegenerative diseases.

J Sport Health Sci. 2016 Dec;5(4):383-387. doi: 10.1016/j.jshs.2016.08.007. Epub 2016 Aug 23.

Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.

Expert Rev Proteomics. 2017 Apr;14(4):285-299. doi: 10.1080/14789450.2017.1304217. Epub 2017 Mar 20.

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189.

Proposed new classification scheme for chemical injury to the human eye.

Regul Toxicol Pharmacol. 2006 Jul;45(2):206-13. doi: 10.1016/j.yrtph.2006.04.005. Epub 2006 Jun 9.

Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.

Prog Neurobiol. 2011 Dec;95(4):517-9. doi: 10.1016/j.pneurobio.2011.11.009. Epub 2011 Nov 22.

Reliable computer-assisted classification of the EEG: EEG variants in index cases and their first degree relatives.

Am J Med Genet. 1996 Feb 16;67(1):1-8. doi: 10.1002/(SICI)1096-8628(19960216)67:1<1::AID-AJMG1>3.0.CO;2-W.

Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.

Eur J Pharm Sci. 2017 Nov 15;109S:S72-S77. doi: 10.1016/j.ejps.2017.08.006. Epub 2017 Aug 13.

Developing a contributing factor classification scheme for Rasmussen's AcciMap: Reliability and validity evaluation.

Appl Ergon. 2017 Oct;64:14-26. doi: 10.1016/j.apergo.2017.04.014. Epub 2017 May 8.

Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.

J Nucl Med. 2016 Mar;57(3):410-5. doi: 10.2967/jnumed.115.165464. Epub 2015 Nov 19.

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease.

Neurochem Int. 2017 Sep;108:355-360. doi: 10.1016/j.neuint.2017.05.010. Epub 2017 May 17.

引用本文的文献

Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach.

J Pers Med. 2020 Nov 11;10(4):221. doi: 10.3390/jpm10040221.

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27.

High Levels of -Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse.

Oxid Med Cell Longev. 2019 Jun 9;2019:5030475. doi: 10.1155/2019/5030475. eCollection 2019.

Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.

Mol Neurobiol. 2019 Sep;56(9):6451-6459. doi: 10.1007/s12035-019-1531-4. Epub 2019 Mar 2.

Current state of Alzheimer's fluid biomarkers.

Acta Neuropathol. 2018 Dec;136(6):821-853. doi: 10.1007/s00401-018-1932-x. Epub 2018 Nov 28.

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.

Front Mol Neurosci. 2018 Feb 22;11:53. doi: 10.3389/fnmol.2018.00053. eCollection 2018.

Precision pharmacology for Alzheimer's disease.

Pharmacol Res. 2018 Apr;130:331-365. doi: 10.1016/j.phrs.2018.02.014. Epub 2018 Feb 16.

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.

Front Aging Neurosci. 2018 Jan 30;10:17. doi: 10.3389/fnagi.2018.00017. eCollection 2018.

Physical activity and prevention of Alzheimer's disease.

J Sport Health Sci. 2016 Dec;5(4):381-382. doi: 10.1016/j.jshs.2016.10.008. Epub 2016 Nov 3.

PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

J Prev Alzheimers Dis. 2016 Dec;3(4):243-259. doi: 10.14283/jpad.2016.112. Epub 2016 Sep 6.

本文引用的文献

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.

Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.

The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Can J Neurol Sci. 2016 Apr;43 Suppl 1:S51-82. doi: 10.1017/cjn.2016.36.

Toward precision medicine in Alzheimer's disease.

Ann Transl Med. 2016 Mar;4(6):107. doi: 10.21037/atm.2016.03.05.

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002.

Alzheimer's disease.

Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189.

Vascular dementia.

Lancet. 2015 Oct 24;386(10004):1698-706. doi: 10.1016/S0140-6736(15)00463-8.

Lewy body dementias.

Lancet. 2015 Oct 24;386(10004):1683-97. doi: 10.1016/S0140-6736(15)00462-6.

Frontotemporal dementia.

Lancet. 2015 Oct 24;386(10004):1672-82. doi: 10.1016/S0140-6736(15)00461-4.

Parkinson's disease.

Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Biomarker-guided classification scheme of neurodegenerative diseases.

J Sport Health Sci. 2016 Dec;5(4):383-387. doi: 10.1016/j.jshs.2016.08.007. Epub 2016 Aug 23.

Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.

Expert Rev Proteomics. 2017 Apr;14(4):285-299. doi: 10.1080/14789450.2017.1304217. Epub 2017 Mar 20.

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189.

Proposed new classification scheme for chemical injury to the human eye.

Regul Toxicol Pharmacol. 2006 Jul;45(2):206-13. doi: 10.1016/j.yrtph.2006.04.005. Epub 2006 Jun 9.

Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.

Prog Neurobiol. 2011 Dec;95(4):517-9. doi: 10.1016/j.pneurobio.2011.11.009. Epub 2011 Nov 22.

Reliable computer-assisted classification of the EEG: EEG variants in index cases and their first degree relatives.

Am J Med Genet. 1996 Feb 16;67(1):1-8. doi: 10.1002/(SICI)1096-8628(19960216)67:1<1::AID-AJMG1>3.0.CO;2-W.

Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.

Eur J Pharm Sci. 2017 Nov 15;109S:S72-S77. doi: 10.1016/j.ejps.2017.08.006. Epub 2017 Aug 13.

Developing a contributing factor classification scheme for Rasmussen's AcciMap: Reliability and validity evaluation.

Appl Ergon. 2017 Oct;64:14-26. doi: 10.1016/j.apergo.2017.04.014. Epub 2017 May 8.

Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.

J Nucl Med. 2016 Mar;57(3):410-5. doi: 10.2967/jnumed.115.165464. Epub 2015 Nov 19.

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease.

Neurochem Int. 2017 Sep;108:355-360. doi: 10.1016/j.neuint.2017.05.010. Epub 2017 May 17.

引用本文的文献

Fluid Candidate Biomarkers for Alzheimer's Disease: A Precision Medicine Approach.

J Pers Med. 2020 Nov 11;10(4):221. doi: 10.3390/jpm10040221.

The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27.

High Levels of -Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse.

Oxid Med Cell Longev. 2019 Jun 9;2019:5030475. doi: 10.1155/2019/5030475. eCollection 2019.

Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.

Mol Neurobiol. 2019 Sep;56(9):6451-6459. doi: 10.1007/s12035-019-1531-4. Epub 2019 Mar 2.

Current state of Alzheimer's fluid biomarkers.

Acta Neuropathol. 2018 Dec;136(6):821-853. doi: 10.1007/s00401-018-1932-x. Epub 2018 Nov 28.

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.

Front Mol Neurosci. 2018 Feb 22;11:53. doi: 10.3389/fnmol.2018.00053. eCollection 2018.

Precision pharmacology for Alzheimer's disease.

Pharmacol Res. 2018 Apr;130:331-365. doi: 10.1016/j.phrs.2018.02.014. Epub 2018 Feb 16.

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.

Front Aging Neurosci. 2018 Jan 30;10:17. doi: 10.3389/fnagi.2018.00017. eCollection 2018.

Physical activity and prevention of Alzheimer's disease.

J Sport Health Sci. 2016 Dec;5(4):381-382. doi: 10.1016/j.jshs.2016.10.008. Epub 2016 Nov 3.

PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease.

J Prev Alzheimers Dis. 2016 Dec;3(4):243-259. doi: 10.14283/jpad.2016.112. Epub 2016 Sep 6.

本文引用的文献

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.

Neurology. 2016 Aug 2;87(5):539-47. doi: 10.1212/WNL.0000000000002923. Epub 2016 Jul 1.

The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis.

Can J Neurol Sci. 2016 Apr;43 Suppl 1:S51-82. doi: 10.1017/cjn.2016.36.

Toward precision medicine in Alzheimer's disease.

Ann Transl Med. 2016 Mar;4(6):107. doi: 10.21037/atm.2016.03.05.

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Alzheimers Dement. 2016 Mar;12(3):292-323. doi: 10.1016/j.jalz.2016.02.002.

Alzheimer's disease.

Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Epub 2016 Feb 24.

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Int J Mol Sci. 2016 Feb 2;17(2):189. doi: 10.3390/ijms17020189.

Vascular dementia.

Lancet. 2015 Oct 24;386(10004):1698-706. doi: 10.1016/S0140-6736(15)00463-8.

Lewy body dementias.

Lancet. 2015 Oct 24;386(10004):1683-97. doi: 10.1016/S0140-6736(15)00462-6.

Frontotemporal dementia.

Lancet. 2015 Oct 24;386(10004):1672-82. doi: 10.1016/S0140-6736(15)00461-4.

Parkinson's disease.

Lancet. 2015 Aug 29;386(9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. Epub 2015 Apr 19.

Biomarker-guided classification scheme of neurodegenerative diseases.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献